Cas:1033-26-7 Bis(4-Nitrophenyl)methanone manufacturer & supplier

We serve Chemical Name:Bis(4-Nitrophenyl)methanone CAS:1033-26-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Bis(4-Nitrophenyl)methanone

Chemical Name:Bis(4-Nitrophenyl)methanone
CAS.NO:1033-26-7
Synonyms:p,p’-dinitrobenzophenone;Methanone,bis(4-nitrophenyl);4,4′-Dinitro-benzophenon;4,4′-dinitro-benzophenone;3,3′-dinitrobenzophenone;Bis-(4-nitro-phenyl)-keton
Molecular Formula:C13H8N2O5
Molecular Weight:272.21300
HS Code:2914700090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:484.7ºC at 760mmHg
Density:1.423g/cm3
Index of Refraction:1.642
PSA:108.71000
Exact Mass:272.04300
LogP:3.78040

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like p,p’-dinitrobenzophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bis-(4-nitro-phenyl)-keton physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis-(4-nitro-phenyl)-keton Use and application,Methanone,bis(4-nitrophenyl) technical grade,usp/ep/jp grade.


Related News: As a global-risk medical practice transforming care of the neediest populations, our centers are located in underserved neighborhoods,” notes Faisel Syed, M.D., ChenMed National Director of Primary Care. azanium,buta-1,3-diene,(E)-4-hydroxy-4-oxobut-2-enoate,styrene manufacturers Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. Furan, 2-[[1-(chloromethyl)-2-(phenylsulfonyl)ethoxy]methyl]- suppliers The Company has run a comprehensive range of specialized in vitro and in vivo tests on its patent-pending novel compounds to select the optimal psychedelic drug candidate for progressing towards human clinical trials. 1-[2-hydroxy-5-(1-hydroxyethyl)phenyl]-3-methylbut-2-en-1-one vendor & factory.